Pyrazolopyranopyrimidines 6aÐc and 8aÐc were prepared from the reaction of compounds 4aÐc or 7aÐc with methylamine or ammonium hydroxide solutions. Treatment of compounds 6aÐc or 8aÐc with 2-chloroethyl methyl ether afforded their corresponding acyclonucleosides 9aÐc or 10aÐc, respectively, as a new class of acyclonucleosides. All prepared compounds were tested as anti-inflammatory agents and some of them revealed moderate to potent antiinflammatory activity.
Introduction
Pyranopyrazoles and pyrazolopyranopyrimidines have attracted the attention of many authors due to their chemical and biological interest (Chantegrel et al., 1985; El-Assiery et al., 2004) , especially their anti-inflammatory activity (Kuo et al., 1984) . Recently, we have been involved in a program (Rashad et al., 2005a, b; Swelam et al., 1999; Zaki, 1998; Zaki et al., 2004) aimed at developing new, simple and efficient syntheses of biologically active heteroaromatic compounds utilizing inexpensive starting materials. In conjunction to these efforts we describe here a synthetic route for preparation of some pyrazolopyranopyrimidines and some of their corresponding acyclonucleosides.
Results and Discussion

Chemistry
Treatment of 3-methyl-2-pyrazolin-5-one (1) with α, -unsaturated nitriles 2aÐc afforded their corresponding 6-amino-4-aryl-3-methyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile derivatives 3aÐc, respectively, as the starting materials for the synthesis (Scheme 1). The structure of the latter compounds was confirmed on the basis of their elemental and spectral data, since the IR spectrum of compound 3a, as a representative example, revealed the presence of cyano and amino
Note:
The interesting readers will receive the chemistry data by direct contact to the authors. Treatment of compounds 3aÐc with an equimolar amount of triethyl orthoformate in the presence of acetic anhydride gave a major product, which could be assigned the structure of 4aÐc or 5aÐc, respectively, due to possible acetylation on either one of the pyrazole nitrogens (Scheme 1). Inspection of 1 H NMR spectra of isomer 4a or 5a, as a representative example, revealed that the signal of C3-methyl protons appeared at δ 2.20 ppm. This is in favor of structure 4a since the C3-methyl protons of structure 5a are adjacent to the N2-acetyl group and so they are more deshielded and their signal would have been observed at lower field. Moreover, the formation of N-acylpyrazoles is governed by the steric interaction between the ring substituents groups and the acyl moiety, and it isomerizes slowly into the more thermodynamically stable form N1-acetyl products (Arakawa et al., 1974a; Kashima, 2003) . This assignment is in accordance with 1 H NMR spectral data given by many authors for alkylation and acylation reactions (Arakawa et al., 1974b; Kuo et al., 1984; Reddy et al., 1963; Zaki et al., 2004) . Also, the 13 C NMR spectrum of compound 4a gives further confirmation for the assigned structure since it 
showed the following signals at (δ, ppm): 156 (C3), 153.86 (C7a), 13.89 (C10). These spectral data are in agreement with the observed data for the C3, C7a, and C10 of related N1-alkyl compounds (Kuo et al., 1984; Zaki et al., 2004) .
As a typical chemical behavior of N-acylpyrazoles towards simple nucleophiles (Zaki et al., 2004) , treatment of compounds 4aÐc with methylamine solution afforded N-{4-(substituted)-pyrano[2,3-d]pyrimidin-5-yl}-methylamine derivatives 6aÐc, respectively, as target compounds for nucleosidation. The IR spectrum of 6a, as a representative example, revealed the absence of a cyano group and the presence of two NH groups; also the ple, revealed the absence of a cyano group and the presence of a NH and NH 2 group. Since the synthesis of acyclovir, as one of the potent antiviral drugs, by Schaeffer et al. (1978) , many attempts have been directed by nucleoside chemists to prepare a lot of relative compounds with various side chain and glycons (Wamhoff et al., 1994; Zeid et al., 1999) , however, acyclonucleosides of pyrazolopyranopyrimidine derivatives were not reported in the literature (to the best of our knowledge). Thus, and in continuation of our previous work (Abdel-Megeid et al., 1998; Rashad and Ali, 2006; Shamroukh et al., 2004) in preparing various cyclic and acyclic nucleosides of different heterocyclic compounds, we describe here the synthesis of some acyclonucleosides of pyrazolopyranopyrimidines by treating the sodium salts of compounds 6aÐc or 8aÐc (generated in situ) with 2-chloroethyl methyl ether to give the corresponding acyclonucleosides 9aÐc or 10aÐc, respectively (Scheme 1). The presence of methoxyethyl protons in the 1 H NMR spectra of compounds 9a and 10a as representative examples, and the absence of the NH signals in the IR and 1 H NMR spectra confirmed their structures.
Deprotection using ammonia/methanol did not affect the acyclonucleosides 9aÐc or 10aÐc, while attempts to deprotect them using alcoholic potassium hydroxide, unfortunately, broke the nucleosidic linkage and gave 6aÐc and 8aÐc again. We believe that compounds 9aÐc and 10aÐc, were the first acyclonucleosides of pyrazolopyranopyrimidines reported in the literature (to the best of our knowledge).
Pharmacology
Animals
Albino male rates (100Ð120 g) were used in the pharmacological test. They were kept under constant conditions and allowed free access to water and standard diet. Biological experiments were performed in accordance with the international guidelines for experimental animal use (WHO, 1982) .
Carrageenan foot paws oedema
The procedure of Winter et al. (1962) was adopted. Albino male rates (100Ð120 g) were dosed orally with the tested compounds dissolved in 5% DMSO in a dose of 40 mg kg Ð1 body mass one hour before carrageenan challenge. Foot paw oedema were induced by injecting 0.10 ml of carrageenan solution subcutaneously into the planter portion in the right hind paw of each rat under light anesthesia. Initial foot paw was weighed immediately following carrageenan challenge. The anti-inflammatory activity was calculated as the percent inhibition after administration of the reference and the tested compounds compared to the control group: % increase in volume of reference Ð inhibition = % increase in volume of tested compound .
% increase in volume of reference A pharmacological study to evaluate the anti-inflammatory effects of the newly synthesized compounds was performed and the results are summarized in Tables I and II . Compound 6a, showed no anti-inflammatory activity with a lower inhibitory effect compared to diclofenac. Compound 6c reduced oedema more effectively than compound 6a with percentage inhibition of 50.40%. Compound 6b reduced oedema more effectively than 6a and 6c with percentage inhibition of 60.10% indicating a high anti-inflammatory effect. Thus, the order of increasing the anti-inflammatory effect is as follows: 6b > 6c > 6a.
According to the mentioned results we can conclude that the anti-inflammatory activity of the tested compounds is enhanced with increasing the aromaticity of the substituted group, where the 3,4-dichlorophenyl group in compound 6a, as an example, showed nonsignificant anti-inflammatory effects compared to the reference (diclofenac) while substitution with a thienyl group slightly increased the anti-inflammatory activity. Further substitution with a naphthyl group gave the highest anti-inflammatory activity. In the course of evaluating the anti-inflammatory activity, we could not detect any significant anti-inflammatory activity for the rest of the tested compounds compared to the reference compound (Table I) except that for compound 8b. These results are in accordance with our findings represented in Table I and indicate the improvement of the anti-inflammatory activity with increasing the aromaticity of the substituted group. Moreover, we can conclude that, the pyranopyrazoles did not reveal any anti-inflammatory activity. Introducing of a pyrimidine ring fused to the pyranopyrazole moiety increases the anti-inflammatory activity. However, further sub- (10%) and propylene glycol (40%) were tried. All compounds were completely soluble in DMSO. 5% DMSO solution in dist. H 2 O was used to prepare doses for oral administration. b Concentration higher than the above mentioned could not be prepared due to precipitation of the compound in the solvent used, 5% DMSO. c 50, 100 and 150 mg/kg were tried for all compounds. The 100 mg/kg dose was used to test and compare the antiinflammatory activity between tested compounds, control and reference compound used (diclofenac). +, slightly active; ++, active; Ð, inactive. stitution with a methoxyethyl group at N1 of the pyrazole ring decreases the anti-inflammatory activity. Thus, the order of increasing the anti-inflammatory effect is as follows: pyrazolopyranopyrimidines > substituted pyrazolopyranopyrimidines > pyranopyrazoles.
Experimental
All melting points are uncorrected and were measured using an Electrothermal IA 9100 apparatus (Shimadzu, Japan). Microanalytical data were performed using a Vario El-Mentar apparatus. The results were found to be in agreement with the calculated values ( ð 0.3). The IR spectra (KBr) were recorded on a Perkin-Elmer 1650 spectrophotometer. 1 H and 13 C NMR spectra were determined on a Jeol 300 MHz in DMSO-d 6 , and the chemical shifts were expressed in ppm relative to TMS as internal reference. Mass spectra were recorded at 70 eV using an EI Ms-QP 1000 EX instrument (Shimadzu, Japan). Column chromatography was performed on Silica gel 60 (particle size 0.06Ð0.2 mm; Merck, Germany).
